bismuth has been researched along with baicalein in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ab Rashid, R; Abdul Razak, K; Abdullah, R; Che Mat, NF; Khairil Anuar, MA; Rahman, WN; Talik Sisin, NN; Zainal Abidin, S | 1 |
| Algethami, M; Dollah, N; Geso, M; Mat, NFC; Rahman, WN; Rashid, RA; Razak, KA; Sisin, NNT | 1 |
2 other study(ies) available for bismuth and baicalein
| Article | Year |
|---|---|
Synergetic Influence of Bismuth Oxide Nanoparticles, Cisplatin and Baicalein-Rich Fraction on Reactive Oxygen Species Generation and Radiosensitization Effects for Clinical Radiotherapy Beams.
Topics: Animals; Bismuth; Brachytherapy; Cisplatin; Drug Synergism; Female; Flavanones; Humans; Iridium Radioisotopes; MCF-7 Cells; Mice; Nanoparticles; NIH 3T3 Cells; Radiation-Sensitizing Agents; Reactive Oxygen Species | 2020 |
Natural Baicalein-Rich Fraction as Radiosensitizer in Combination with Bismuth Oxide Nanoparticles and Cisplatin for Clinical Radiotherapy.
Topics: Bismuth; Cisplatin; Flavanones; Humans; Nanoparticles; Radiation-Sensitizing Agents; Radiotherapy | 2022 |